3-38712241-A-T

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_006514.4(SCN10A):​c.4009T>A​(p.Ser1337Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00538 in 1,614,206 control chromosomes in the GnomAD database, including 46 homozygotes. In-silico tool predicts a benign outcome for this variant. 17/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0044 ( 5 hom., cov: 33)
Exomes 𝑓: 0.0055 ( 41 hom. )

Consequence

SCN10A
NM_006514.4 missense

Scores

18

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:11

Conservation

PhyloP100: -3.70

Publications

13 publications found
Variant links:
Genes affected
SCN10A (HGNC:10582): (sodium voltage-gated channel alpha subunit 10) The protein encoded by this gene is a tetrodotoxin-resistant voltage-gated sodium channel alpha subunit. The properties of the channel formed by the encoded transmembrane protein can be altered by interaction with different beta subunits. This protein may be involved in the onset of pain associated with peripheral neuropathy. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jun 2014]
SCN10A Gene-Disease associations (from GenCC):
  • sodium channelopathy-related small fiber neuropathy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • episodic pain syndrome, familial, 2
    Inheritance: AD Classification: LIMITED, NO_KNOWN Submitted by: Labcorp Genetics (formerly Invitae), Illumina, Ambry Genetics
  • Brugada syndrome
    Inheritance: Unknown Classification: LIMITED Submitted by: Genomics England PanelApp
  • Brugada syndrome 1
    Inheritance: AD Classification: NO_KNOWN Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0060340464).
BP6
Variant 3-38712241-A-T is Benign according to our data. Variant chr3-38712241-A-T is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 235224.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population mid. GnomAdExome4 allele frequency = 0.00548 (8010/1461854) while in subpopulation MID AF = 0.0231 (133/5768). AF 95% confidence interval is 0.0199. There are 41 homozygotes in GnomAdExome4. There are 3919 alleles in the male GnomAdExome4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High AC in GnomAd4 at 673 AD,Unknown gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
SCN10ANM_006514.4 linkc.4009T>A p.Ser1337Thr missense_variant Exon 23 of 28 ENST00000449082.3 NP_006505.4

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
SCN10AENST00000449082.3 linkc.4009T>A p.Ser1337Thr missense_variant Exon 23 of 28 1 NM_006514.4 ENSP00000390600.2
SCN10AENST00000643924.1 linkc.4006T>A p.Ser1336Thr missense_variant Exon 22 of 27 ENSP00000495595.1
SCN10AENST00000655275.1 linkc.4033T>A p.Ser1345Thr missense_variant Exon 23 of 28 ENSP00000499510.1

Frequencies

GnomAD3 genomes
AF:
0.00443
AC:
675
AN:
152234
Hom.:
5
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00109
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00693
Gnomad ASJ
AF:
0.00202
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00166
Gnomad FIN
AF:
0.000471
Gnomad MID
AF:
0.0285
Gnomad NFE
AF:
0.00701
Gnomad OTH
AF:
0.00860
GnomAD2 exomes
AF:
0.00459
AC:
1154
AN:
251418
AF XY:
0.00461
show subpopulations
Gnomad AFR exome
AF:
0.000677
Gnomad AMR exome
AF:
0.00486
Gnomad ASJ exome
AF:
0.00218
Gnomad EAS exome
AF:
0.0000544
Gnomad FIN exome
AF:
0.000739
Gnomad NFE exome
AF:
0.00719
Gnomad OTH exome
AF:
0.00766
GnomAD4 exome
AF:
0.00548
AC:
8010
AN:
1461854
Hom.:
41
Cov.:
32
AF XY:
0.00539
AC XY:
3919
AN XY:
727228
show subpopulations
African (AFR)
AF:
0.00119
AC:
40
AN:
33474
American (AMR)
AF:
0.00552
AC:
247
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.00207
AC:
54
AN:
26136
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39700
South Asian (SAS)
AF:
0.00198
AC:
171
AN:
86258
European-Finnish (FIN)
AF:
0.00105
AC:
56
AN:
53420
Middle Eastern (MID)
AF:
0.0231
AC:
133
AN:
5768
European-Non Finnish (NFE)
AF:
0.00626
AC:
6962
AN:
1111982
Other (OTH)
AF:
0.00575
AC:
347
AN:
60392
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
487
974
1462
1949
2436
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
256
512
768
1024
1280
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00442
AC:
673
AN:
152352
Hom.:
5
Cov.:
33
AF XY:
0.00427
AC XY:
318
AN XY:
74506
show subpopulations
African (AFR)
AF:
0.00108
AC:
45
AN:
41588
American (AMR)
AF:
0.00693
AC:
106
AN:
15306
Ashkenazi Jewish (ASJ)
AF:
0.00202
AC:
7
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5192
South Asian (SAS)
AF:
0.00145
AC:
7
AN:
4826
European-Finnish (FIN)
AF:
0.000471
AC:
5
AN:
10620
Middle Eastern (MID)
AF:
0.0272
AC:
8
AN:
294
European-Non Finnish (NFE)
AF:
0.00701
AC:
477
AN:
68026
Other (OTH)
AF:
0.00851
AC:
18
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
37
74
110
147
184
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00654
Hom.:
2
Bravo
AF:
0.00496
TwinsUK
AF:
0.00566
AC:
21
ALSPAC
AF:
0.00545
AC:
21
ESP6500AA
AF:
0.000681
AC:
3
ESP6500EA
AF:
0.00651
AC:
56
ExAC
AF:
0.00447
AC:
543
Asia WGS
AF:
0.00202
AC:
7
AN:
3478
EpiCase
AF:
0.00671
EpiControl
AF:
0.00877

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:11
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:5
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

Sep 01, 2025
CeGaT Center for Human Genetics Tuebingen
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

SCN10A: BP4, BS1, BS2

Apr 01, 2016
Center for Pediatric Genomic Medicine, Children's Mercy Hospital and Clinics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

not specified Benign:3
Clinical Genetics, Academic Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

Dec 21, 2016
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease.

Aug 27, 2024
Women's Health and Genetics/Laboratory Corporation of America, LabCorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

SCN10A-related disorder Benign:1
Apr 17, 2019
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications).

Brugada syndrome Benign:1
Jan 30, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Cardiovascular phenotype Benign:1
Jan 09, 2019
Ambry Genetics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity.

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.086
BayesDel_addAF
Benign
-0.41
T
BayesDel_noAF
Benign
-0.35
CADD
Benign
0.010
DANN
Benign
0.26
DEOGEN2
Benign
0.38
T;.;T;.
Eigen
Benign
-1.6
Eigen_PC
Benign
-1.7
FATHMM_MKL
Benign
0.010
N
LIST_S2
Benign
0.0
.;T;T;T
M_CAP
Benign
0.078
D
MetaRNN
Benign
0.0060
T;T;T;T
MetaSVM
Benign
-0.32
T
MutationAssessor
Benign
0.90
L;.;L;.
PhyloP100
-3.7
PrimateAI
Benign
0.32
T
PROVEAN
Benign
-0.62
N;.;.;.
REVEL
Benign
0.18
Sift
Benign
0.57
T;.;.;.
Sift4G
Benign
0.43
T;.;.;.
Vest4
0.13
ClinPred
0.0074
T
GERP RS
-9.3
Varity_R
0.047
gMVP
0.27
Mutation Taster
=95/5
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs11711062; hg19: chr3-38753732; COSMIC: COSV101479357; API